Response Genetics (RGDX) Tops Q3 EPS by 1c
More News related to RGDX
- Response Genetics to Present at the 20th Annual UBS Global Healthcare Services Conference and at the 12th Annual BIO CEO & Investor Conference
- Response Genetics Announces Appointment of Dr. Edith P. Mitchell to Board of Directors
- Response Genetics (RGDX) Expanding ResponseDX Sales Force to Meet Demand
- Response Genetics to Increase Sales Force by 50 percent to Meet Growing Demand for its ResponseDX(TM) Tests
- Response Genetics (RGDX) and Genetic Tech (GENE) Announce Distribution Agreement
More News related to Earnings
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
- RenaissanceRe (RNR) Tops Q4 Views
Response Genetics Inc. (Nasdaq: RGDX) reports a Q3 loss of $0.14, 1 cent better than estimates.
Total revenue increased by 15% to $2.3 million for the third quarter vs. consensus of $2.21 million.
[SM]
Related Categories
EarningsStocks Mentioned
+0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
